Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

News

News Avicenna Alliance sent letter to Australian Minister Andrews

Avicenna Alliance sent letter to Australian Minister Andrews

On 28 October, the Avicenna Alliance sent a letter to the Australian Minister for Industry, Science and Technology Karen Andrews MP asking to contribute to international discussions on how to ensure that computer modelling and simulation (CM&S) can help enable the healthcare sector to improve patient safety.

News Exploristics joins the Avicenna Alliance

Exploristics joins the Avicenna Alliance

The Avicenna Alliance is proud to announce the newest addition to its list of members: Exploristics. Based in Belfast, Exploristics provide world-class analytics through specialised software products and services to pharmaceutical and life sciences sectors.

News Avicenna present at the European Research & Innovation Days

Avicenna present at the European Research & Innovation Days

The European Research and Innovation days was a three-day event in Brussels, during which researchers, academics, businesses, decision-makers and parliament representatives from Europe and beyond took part in a co-design process to shape the priorities and strategic plan for the first four years of Horizon Europe, due to start in 2021.

News SAVE THE DATE! Ansys-FDA-Avicenna event in Washington on 11 October 2019

SAVE THE DATE! Ansys-FDA-Avicenna event in Washington on 11 October 2019

Innovation through healthcare simulationFor those of you who will be in Washington mid-October, ANSYS, in cooperation with the FDA and the Avicenna Alliance, is organizing a roundtable discussion titled "Transforming Computational Modeling from A Valuable Scientific Tool to A Valuable Regulatory Tool: Myth or Reality?"

News Avicenna answers online consultation to shape Horizon Europe

Avicenna answers online consultation to shape Horizon Europe

On 23 July the Avicenna Alliance has submitted its opinion to on the strategic priorities of Horizon Europe, the EU’s next framework programme for research and innovation (R&I). The Commission had indeed launched an online consultation addressed to individuals and organisations with an interest in the future EU R&I priorities.

News Prestigious FDA award allocated to group that developed the V&V 40 standard

Prestigious FDA award allocated to group that developed the V&V 40 standard

The Avicenna Alliance is proud to announce that some of its working group members have received the FDA Crosscutting Group Honor Award on 2 August 2019.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2026 Avicenna Alliance | powered by We Berry